Relationship Between Diagnostic Methods And Hematological Parameters In Testicular Cancer

Yıl 2025, Cilt: 47 Sayı: 1, 133 - 139, 17.01.2025

Veli Mert Yazar , Arif Bedirhan Bayraktar , Osman Gercek , Melih Şenkol

Öz

Testicular cancer is the most common solid malignancy in young adult males. The aim of this study is to investigate the relationship between hematological parameters in testicular tumors and traditional methods used in diagnosis. Sixty-eight patients who underwent radical orchiectomy due to testicular tumor were retrospectively analyzed. Age, presenting complaint, tumor side, radiological tumor size, pathological tumor size, preoperative tumor markers (AFP, β-hCG, LDH) of the patients were recorded. In addition preoperative hemogram parameters of the patients; WBC, neutrophil, lymphocyte, monocyte, basophil, eosinophil, hemoglobin, platelet, mean corpuscular volume , mean platelet volume, platelet distribution width were recorded. In addition, systemic inflammatory markers obtained from hemogram parameters such as neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, monocyte-lymphocyte ratio, monocyte-platelet ratio, systemic immune-inflammatory index, systemic inflammatory response index, systemic inflammatory aggregate index were calculated and recorded. When hematological parameters were examined; lymphocyte count was determined as 2.26±0.58 ×103/μL in the seminoma group and was significantly higher than in the non-seminoma group (p=0.020). WBC, MCV, MPV, PDW, neutrophil, monocyte basophil, eosinophil and hemoglobin and platelet values were similar in both groups (all p>0.05). NLR, PLR, SII values were observed to be higher in the non-seminoma group and MPR value was observed to be higher in the seminoma group (p=0.03, p=0.004, p=0.01, p=0.04, respectively). Inflammation indices derived from complete blood count are low-cost, reliable and easily accessible parameters that do not require additional examination. These indices can be used to predict histological subgroups of germ cell testicular tumors before surgery and to support pathological diagnosis.

Anahtar Kelimeler

Testicular Tumor, Neutrophil, Germ Cell Tumors

Testis Kanserinde Hematolojik Parametrelerin Tani Yöntemleri İle Olan İlişkisi

Öz

Testis kanseri, genç yetişkin erkeklerde en sık görülen solid malignitedir. Bu çalışmanın amacı testis tümörlerindeki meydana gelen hematolojik parametrelerin, tanıda kullanılan geleneksel yöntemler ile ilişkisini araştırmaktadır. Testis tümörü nedeniyle radikal orşiektomi uygulanan 68 hasta retrospektif olarak incelendi. Hastaların yaş, başvuru şikayeti, tümör tarafı, radyolojik tümör boyutu, patolojik tümör boyutu, preoperatif tümör belirteçleri (AFP, β-hCG. LDH) kaydedildi. Ayrıca hastaların preoperatif hemogram parametrelerinden; WBC, nötrofil, lenfosit, monosit, bazofil, eozinofil, hemoglobin, platelet, ortalama korpüsküler hacim, ortalama trombosit hacmi, platelet dağılım genişliği değerleri kaydedildi. Ayrıca hemogram parametrelerinden elde edilen sistemik inflamatuvar belirteçler olan nötrofil lenfosit oranı, platelet lenfosit oranı, monosit lenfosit oranı, monosit platelet oranı, sistemik immün-inflamatuar indeks, sistemik inflamatuar response indeks, sistemik inflamatuar agregat indeks değerleri hesaplandı ve kaydedildi. Hematolojik parametreler incelendiğinde; lenfosit sayısı seminom grubunda 2,26±0,58 ×103/μL olarak saptanmış olup, non-seminom grubuna göre anlamlı yüksekti (p=0,020). WBC, MCV, MPV, PDW, nötrofil, monosit bazofil, eozinofil ve hemoglobin ve platelet değerleri her iki grupta benzerdi (hepsi p>0,05). NLR, PLR, SII değerleri non-seminom grubunda, MPR değeri ise seminom grubunda yüksek izlenmiştir (sırasıyla; p=0,03, p=0,004, p=0,01, p=0,04). Tam kan sayımından türetilen inflamasyon indeksleri ek tetkik gerektirmeyen maliyet düşük, güvenilir ve kolayca erişilebilir parametrelerdir. Bu indeksler ameliyat önce germ hücreli testis tümörlerinin histolojik alt gruplarını öngörme ve patolojik tanıyı destekleme amacıyla kullanılabilir.

Anahtar Kelimeler

Testis tümörü, Nötrofil, Germ hücreli tümörler

Etik Beyan

Yapılan çalışmada, araştırma ve yayın etiğine uyulmuştur.

Kaynakça

• 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7-30.
• 2. Park JS, Kim J, Elghiaty A, Ham WS. Recent global trends in testicular cancer incidence and mortality. Medicine (Baltimore). 2018;97(37):e12390.
• 3. Smith ZL, Werntz RP, Eggener SE. Testicular Cancer: Epidemiology, Diagnosis, and Management. Med Clin North Am. 2018;102(2):251-64.
• 4. De Toni L, Šabovic I, Cosci I, Ghezzi M, Foresta C, Garolla A. Testicular cancer: Genes, environment, hormones. Frontiers in endocrinology. 2019;10:408.
• 5. Germà-Lluch JR, Garcia del Muro X, Maroto P, Paz-Ares L, Arranz JA, Gumà J, et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol. 2002;42(6):553-62; discussion 62-3.
• 6. Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, et al. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol. 2013;24(4):878-88.
• 7. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. Guidelines on Testicular Cancer: 2015 Update. Eur Urol. 2015;68(6):1054-68.
• 8. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-44. 9. Sfanos KS, Yegnasubramanian S, Nelson WG, De Marzo AM. The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol. 2018;15(1):11-24.
• 10. Huszno J, Kołosza Z, Mrochem-Kwarciak J, Telka E, Jochymek B, Miszczyk L. Role of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio and platelets in prognosis of patients with prostate cancer. Oncol Lett. 2022;24(3):305.
• 11. Moch H, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, et al. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2022;82(5):458-68.
• 12. Chung P, Warde P. Testicular cancer: germ cell tumours. BMJ Clin Evid. 2016;2016.
• 13. Sionov RV, Fridlender ZG, Granot Z. The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment. Cancer Microenviron. 2015;8(3):125-58.
• 14. Vasdev N, Moon A, Thorpe AC. Classification, epidemiology and therapies for testicular germ cell tumours. Int J Dev Biol. 2013;57(2-4):133-9.
• 15. Dieckmann KP, Simonsen-Richter H, Kulejewski M, Anheuser P, Zecha H, Isbarn H, et al. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment. Biomed Res Int. 2019;2019:5030349.
• 16. Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-22.
• 17. Schaider H, Oka M, Bogenrieder T, Nesbit M, Satyamoorthy K, Berking C, et al. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer. 2003;103(3):335-43.
• 18. McCourt M, Wang J, Sookhai S, Redmond H. Proinflammatory Mediators Stimulate Neutrophil-Directed Angiogenesis. Archives of surgery (Chicago, Ill : 1960). 2000;134:1325-31; discussion 31.
• 19. Di Carlo E, Forni G, Musiani P. Neutrophils in the antitumoral immune response. Chem Immunol Allergy. 2003;83:182-203.
• 20. McCourt M, Wang JH, Sookhai S, Redmond HP. Activated human neutrophils release hepatocyte growth factor/scatter factor. Eur J Surg Oncol. 2001;27(4):396-403.
• 21. Yuksel OH, Verit A, Sahin A, Urkmez A, Uruc F. White blood cell counts and neutrophil to lymphocyte ratio in the diagnosis of testicular cancer: a simple secondary serum tumor marker. Int Braz J Urol. 2016;42(1):53-9.
• 22. Olcucu MT, Karamik K, Yilmaz K, Okuducu Y, Cakir S, Ates M. Preoperative Inflammation Markers and De Ritis Ratio in Predicting Clinical Presentation and Prognosis of Patients with Testicular Germ Cell Tumors. J Coll Physicians Surg Pak. 2020;30(10):1041-6.
• 23. Klepp O, Flodgren P, Maartman-Moe H, Lindholm CE, Unsgaard B, Teigum H, et al. Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA). Ann Oncol. 1990;1(4):281-8.
• 24. Wang S, Yang X, Yu Z, Du P, Cao Y, Ji Y, et al. The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting testicular germ cell tumors: A retrospective clinical study. Front Oncol. 2022;12:893877.
• 25. Zhang Y, Lin S, Yang X, Wang R, Luo L. Prognostic value of pretreatment systemic immune-inflammation index in patients with gastrointestinal cancers. J Cell Physiol. 2019;234(5):5555-63.
• 26. Imamoglu GI, Eren T, Baylan B, Karacın C. May High Levels of Systemic Immune-Inflammation Index and Hematologic Inflammation Markers Suggest a Further Stage in Testicular Tumours? Urol Int. 2019;103(3):303-10.
• 27. Salazar-Valdivia FE, Valdez-Cornejo VA, Ulloque-Badaracco JR, Hernandez-Bustamante EA, Alarcón-Braga EA, Mosquera-Rojas MD, et al. Systemic Immune-Inflammation Index and Mortality in Testicular Cancer: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2023;13(5).
• 28. Şimşekoğlu MF, Vural A, Macit M, Yıldız F, Kalender G, Aferin U, et al. The clinical value of complete blood count-based immun parameter in predicting testicular cancer pathology and prognosis. Anatolian Clinic the Journal of Medical Sciences. 2024;29(2):210-6.
• 29. Bumbasirevic U, Bojanic N, Simic T, Milojevic B, Zivkovic M, Kosanovic T, et al. Interplay between Comprehensive Inflammation Indices and Redox Biomarkers in Testicular Germ-Cell Tumors. J Pers Med. 2022;12(5).